We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Shah - Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity
Gunjan Shah, MD, MS
Tufts Medical Center
Boston, MA
12.03.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles